Items where Author is "<span class="person_name">Rahalkar, Hasumati</span>"
Number of items: 5.
Article
  • Current Regulatory Requirements for Biosimilars in Six Member Countries of BRICS-TM: Challenges and Opportunities. (2021) Hasumati Rahalkar, Alan Sheppard, Gustavo Mendes Lima Santos, Chitralekha Dasgupta, Sonia Mayra Perez-Tapia, Carlos A. Lopez-Morales and Sam Salek
  • Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices. (2021) Hasumati Rahalkar, Alan Sheppard and Sam Salek
  • Challenges Faced by the Biopharmaceutical Industry in the Development and Marketing Authorization of Biosimilar Medicines in BRICS-TM Countries: An Exploratory Study. (2021) Hasumati Rahalkar, Alan Sheppard, Carlos Augusto Lopez-Morales, Luciano Lobo and Sam Salek
    • Thesis
  • Evaluation of the Regulatory Requirements for Development and Approval of Biosimilar Medicines in the BRICS-TM Countries: Improving Patients' Access. (2021) Hasumati Rahalkar
    • Other
  • Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory Guidelines. (2018) Hasumati Rahalkar, Hacer Coskun Cetintas and Mir-Saeed Shayegan Salek